Incidentally detected inoperable malignant pheochromocytoma with hepatic metastasis treated by transcatheter arterial chemoembolization

Endocrinology and Metabolism

Volumn 29, Issue 4, 2014, Pages 584-589

  Kim, Joong Keun ^a   Kim, Bo Hyun ^a   Baek, Sung Min ^a   Shin, Dong Hun ^a   Kim, Won Jin ^a   Jeon, Yun Kyoung ^a   Kim, Sang Soo ^a   Kim, In Joo ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Liver metastasis; Malignant pheochromocytoma; Transcatheter arterial chemoembolization

Indexed keywords

EID: 84945942984     PISSN: 2093596X     EISSN: 20935978     Source Type: Journal    
DOI: 10.3803/EnM.2014.29.4.584     Document Type: Article

References (12)

1. Gruber M, Darr R, Eisenhofer G. Pheochromocytoma: update on diagnosis and therapy. Dtsch Med Wochenschr 2014;139:486-90.
2. Hidaka S, Hiraoka A, Ochi H, Uehara T, Ninomiya T, Miyamoto Y, Hasebe A, Tanihira T, Tanabe A, Ichiryu M, Nakahara H, Tazuya N, Ninomiya I, Michitaka K. Malignant pheochromocytoma with liver metastasis treated by transcatheter arterial chemo-embolization (TACE). Intern Med 2010;49:645-51.
3. Hori T, Yamagiwa K, Hayashi T, Yagi S, Iida T, Taniguchi K, Kawarada Y, Uemoto S. Malignant pheochromocytoma: Hepatectomy for liver metastases. World J Gastrointest Surg 2013;5:309-13.
4. Fishbein L, Orlowski R, Cohen D. Pheochromocytoma/paraganglioma: review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma. J Clin Hypertens (Greenwich) 2013; 15:428-34.
5. Martucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer 2014;38:7-41.
6. Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 1981;56:354-60.
7. Mlika M, Kourda N, Zorgati MM, Bahri S, Ben Ammar S, Zermani R. Prognostic value of Pheochromocytoma of the Adrenal Gland Scaled Score (Pass score) tests to separate benign from malignant neoplasms. Tunis Med 2013;91: 209-15.
8. Scholz T, Eisenhofer G, Pacak K, Dralle H, Lehnert H. Clinical review: current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 2007;92:1217-25.
9. Hodin R, Lubitz C, Phitayakorn R, Stephen A. Diagnosis and management of pheochromocytoma. Curr Probl Surg 2014; 51:151-87.
10. Morikawa T, Suzuki M, Unno M, Endo K, Katayose Y, Matsuno S. Malignant pheochromocytoma with hepatic metastasis diagnosed 10 years after a resection of the primary incidentaloma adrenal lesion: report of a case. Surg Today 2001; 31:80-4.
11. Gimenez-Roqueplo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res 2012; 44:328-33.
12. Lowery AJ, Walsh S, McDermott EW, Prichard RS. Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas. Oncologist 2013;18:391-407.